Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,440
-10 (-0.09%)
Nov 18, 2024, 3:19 PM KST

Vaxcell-Bio Therapeutics Revenue

Vaxcell-Bio Therapeutics had revenue of 29.24M KRW in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to 69.60M. In the year 2023, Vaxcell-Bio Therapeutics had annual revenue of 13.72M.

Revenue (ttm)
69.60M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
263.27B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.72M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition